tangjy tang

Prof. tangjy tang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Phytomedicine
Verified
Journal Article
Closed access
YCYu-Ying Chen
Yu-Ying Chen
QLQiu-Ping Liu
Qiu-Ping Liu
PAPei An
Pei An
MJMin Jia
Min Jia
XLXin Luan
Xin Luan
HZHong Zhang
Hong Zhang

9 January 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
JLJingwen Liu
Jingwen Liu
JZJing Zhou
Jing Zhou
YLYuling Luan
Yuling Luan
XLXiaoying Li
Xiaoying Li
XMXiangrui Meng
Xiangrui Meng
ZWZhilei Wang
Zhilei Wang
Background: Intracellular DNA-sensing pathway cGAS-STING, inflammasomes and pyroptosis act as critical natural immune signaling axes for microbial infection, chronic inflammation, cancer progression and organ degeneration, but the mechanism and regulation of the crosstalk network remain unclear. Main body of the Cellular stress disrupts mitochondrial homeostasis, facilitates the opening of mitochondrial permeability transition pore and the leakage of mitochondrial DNA to cell membrane, triggers inflammatory responses by activating cGAS-STING signaling, and subsequently induces inflammasomes activation and the onset of pyroptosis. Meanwhile, the inflammasome-associated protein caspase-1, Gasdermin D, the CARD domain of ASC and the potassium channel are involved in regulating cGAS-STING pathway. Importantly, this crosstalk network has a cascade amplification effect that exacerbates the immuno-inflammatory response, worsening the pathological process of inflammatory and autoimmune diseases. Given the importance of this crosstalk network of cGAS-STING, inflammasomes and pyroptosis in the regulation of innate immunity, it is emerging as a new avenue to explore the mechanisms of multiple disease pathogenesis. Therefore, efforts to define strategies to selectively modulate cGAS-STING, inflammasomes and pyroptosis in different disease settings have been or are ongoing. In this review, we will describe how this mechanistic understanding is driving possible therapeutics targeting this crosstalk network, focusing on the interacting or regulatory proteins, pathways, and a regulatory mitochondrial hub between cGAS-STING, inflammasomes, and pyroptosis. Short conclusion: This review aims to provide insight into the critical roles and regulatory mechanisms of the crosstalk network of cGAS-STING, inflammasomes and pyroptosis, and to highlight some promising directions for future research and intervention.

1 January 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ZZZhongzhen Zeng
Zhongzhen Zeng
QNQing Nian
Qing Nian
NCNianzhi Chen
Nianzhi Chen
MZMaoyuan Zhao
Maoyuan Zhao
QZQiao Zheng
Qiao Zheng
TTtangjy tang
tangjy tang
Ginsenoside Rg3 (GRg3) is a ginsenoside extracted from Panax ginseng. GRg3 displays multiple pharmacological properties, such as antitumor, anti-inflammatory, antioxidative and antifibrotic properties. However, whether GRg3 inhibits angiogenesis in gastric precancerous lesions (GPLs) and the possible mechanisms remain unknown. GRg3 attenuated gastric intestinal metaplasia and gastric dysplasia, the hallmark of GPL pathology, in rats with MNNG-ammonia compound induced GPLs. Increased CD34+ microvessel density and VEGF expression, which indicate the presence of angiogenesis, were evident in the rats with GPLs. GRg3 administration reduced VEGF protein expression and CD34+ microvessel density. In addition, GRg3 was capable of attenuating microvascular abnormalities. Data analysis revealed that enhanced protein expression of GLUT1, GLUT3 and GLUT4 were present in both human and animal GPL specimens. The administration of GRg3 caused significant decreases in the mRNA and protein expression levels of GLUT1 and GLUT4 in the rats with GPLs. However, the GRg3-treated rats with GPLs did not demonstrate regulatory effects on GLUT3, GLUT6, GLUT10, and GLUT12. Consistent with in vitro results, GRg3 administration significantly reduced the protein expression levels of GLUT1 and GLUT4 in both AGS and HGC-27 human gastric cancer cells in vitro. In conclusion, GRg3 can attenuate angiogenesis and temper microvascular abnormalities in rats with GPLs, which may be associated with its inhibition on the aberrant activation of GLUT1 and GLUT4.

6 June 2023 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
JHJu Huang
Ju Huang
YZYu Zhu
Yu Zhu
HXHang Xiao
Hang Xiao
JLJingwen Liu
Jingwen Liu
SLSongtao Li
Songtao Li
XMxiangrui meng
xiangrui meng
Traditional Chinese medicine (TCM) has been used for centuries to prevent and treat a variety of illnesses, and its popularity is increasing worldwide. However, the clinical applications of natural active components in TCM are hindered by the poor solubility and low bioavailability of these compounds. To address these issues, Chinese medicine self-assembly nanostrategy (CSAN) is being developed. Many active components of TCM possess self-assembly properties, allowing them to form nanoparticles (NPs) through various noncovalent forces. Self-assembled NPs (SANs) are also present in TCM decoctions, and they are closely linked to the therapeutic effects of these remedies. SAN is gaining popularity in the nano research field due to its simplicity, eco-friendliness, and enhanced biodegradability and biocompatibility compared to traditional nano preparation methods. The self-assembly of active ingredients from TCM that exhibit antitumour effects or are combined with other antitumour drugs has generated considerable interest in the field of cancer therapeutics. This paper provides a review of the principles and forms of CSAN, as well as an overview of recent reports on TCM that can be used for self-assembly. Additionally, the application of CSAN in various cancer diseases is summarized, and finally, a concluding summary and thoughts are proposed. We strongly believe that CSAN has the potential to offer fresh strategies and perspectives for the modernization of TCM.

25 November 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
SLSongtao Li
Songtao Li
XMXiangrui Meng
Xiangrui Meng
BPBo Peng
Bo Peng
JHJu Huang
Ju Huang
JLJingwen Liu
Jingwen Liu
TTtangjy tang
tangjy tang

27 July 2023 in Science of The Total Environment
Verified
Journal Article
Closed access
YMYu Mou
Yu Mou
WLWenhao Liao
Wenhao Liao
YLYun Liang
Yun Liang
YLYuchen Li
Yuchen Li
MZMei Zhao
Mei Zhao
ZWZhilei Wang
Zhilei Wang